GANX icon

Gain Therapeutics
GANX

Overview Fund Activity

19 hedge funds and large institutions have $9.77M invested in Gain Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 11 closing their positions.

Holders
19
Holders Change
-9
Holders Change %
-32.14%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
11
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
+$18K

Top Buyers

1
GAM
1
Gotham Asset Management
New York
$7.38M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$484K
3
Jones Financial Companies
3
Jones Financial Companies
Missouri
$106K
4
SCP
4
Sandhill Capital Partners
New York
$27.4K
5
TRCT
5
Tower Research Capital (TRC)
New York
$8.62K

Top Sellers

1
TIM
1
Timelo Investment Management
Ontario, Canada
$0
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$0
3
HWM
3
Hohimer Wealth Management
Washington
$0
4
CCC
4
Cable Car Capital
California
$0
5
Renaissance Technologies
5
Renaissance Technologies
New York
$94.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
26
Bridgeway Capital Management
Texas
– -$51.2K -40,000 Closed
VF
27
Virtu Financial
New York
– -$35K -27,356 Closed
Millennium Management
28
Millennium Management
New York
– -$29.9K -23,373 Closed
GC
29
Gilbert & Cook
Iowa
– -$12.8K -10,000 Closed
1
2